


Infectious Diseases Clinical Research
We aim to eliminate the public health threat of infectious diseases by supporting the global elimination targets in the United Nations Sustainable Development Goals.
About
We're an interdisciplinary team of clinicians, epidemiologists, social scientists and public health practitioners. Our aim is to improve our understanding of infectious diseases and their transmission, prevention, care and cure. We focus on prevention, diagnosis and management of blood borne viruses for people living with these diseases. This includes viral hepatitis and HIV.
We examine novel models of care and conduct clinical trials based on implementation science. The goal is to increase knowledge and improve health outcomes for affected communities.
We work closely with affected populations including:
- people who inject drugs
- people from culturally and linguistically diverse communities
- men who have sex with men
- the Aboriginal and Torres Strait Islander community
- people incarcerated or engaged with the criminal justice system
- people at risk of homelessness.
We also engage and collaborate with:
- key stakeholder and affected community groups and organisations
- public health units
- state and federal governments
- pharmacy organisations
- Aboriginal Community Controlled Health Organisations.
Our health outcomes have led to changes in national and global guidelines in testing, care and treatment for communities living with infectious diseases.
To improve the health of people living with infectious diseases, we've directly supported:
- the roll out of new testing strategies
- new person-centred models of care
- new treatment
- health systems change.
Current projects
View 4 more
Barriers to hepatocellular carcinoma screening uptake in Victoria
People with hepatocellular carcinoma risk factors are recommended to have twice-yearly cancer screenings. We explore barriers to screening adherence.

EXPAND-C: hepatitis C testing and treatment through community pharmacies
Expanding access to hepatitis C testing and treatment using a pharmacy-based model.
Eliminate Hepatitis C Australia (EC Australia)
Partnering to eliminate hepatitis C as a public health threat by 2030.
Past projects

PharmEC REACH study: reaching methadone users attending community pharmacies with HCV
This project assesses the effectiveness, feasibility and cost-effectiveness of nurse-led testing and treatment of hepatitis C in community pharmacies for people on opiate substitution therapy.

The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

Eliminate C (EC) Victoria partnership
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
News and features
Group contacts

Professor Joseph (Joe) Doyle
Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow
Group members

Dr Amanda Wade
Post-Doc

Dr Aoife Hurley
Public Health Registrar

Ashleigh Stewart
Postdoctoral Research Fellow

Brendan Harney
Research Assistant

Dr Caitlin Douglass
Senior Research Officer

Dr Elly Layton
Public Health Registrar

Dr Imogen Elsum
Research Program Manager

Dr Jacqui Richmond
Program Manager, Workforce Development and Health Service Delivery, EC Australia

Professor Joseph (Joe) Doyle
Deputy Program Director, Disease Elimination; Co-Head, Infectious Diseases Clinical Research; President, Hepatitis Australia; NHMRC Clinical Research Fellow

Kate Allardice RN RM (she/her)
Senior Research Nurse – Disease Elimination

Dr Katie Heath
Senior Research Officer

Limya Eisa
Research Assistant

Professor Mark A Stoové
Head of Public Health

Professor Margaret Hellard AM
Deputy Director, Programs; Adjunct Professor, Monash University, DEPM.

Mellissa Bryant
Senior Researcher

Rodney Guzman
Clinical Research Nurse – QuickStart Study

Dr Stephanie Munari
PhD candidate; Senior Research Officer
